{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T15:56:29Z","timestamp":1794412589492,"version":"4.9.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Hospital Fund of the Affiliated Hospital of Hebei University","award":["2022QA09"],"award-info":[{"award-number":["2022QA09"]}]},{"name":"Baoding Science and Technology Plan Project","award":["2241ZF322"],"award-info":[{"award-number":["2241ZF322"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"DOI":"10.1186\/s12894-025-01760-4","type":"journal-article","created":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T02:18:39Z","timestamp":1743992319000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Cytokeratin 17 activates AKT signaling to induce epithelial-mesenchymal transition and promote bladder cancer progression"],"prefix":"10.1186","volume":"25","author":[{"given":"Pei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingkai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuijuan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianhe","family":"Zu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuemian","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyu","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,7]]},"reference":[{"key":"1760_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"1760_CR2","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.eururo.2016.06.010","volume":"71","author":"S Antoni","year":"2017","unstructured":"Antoni S, Ferlay J, Soerjomataram I, et al. Bladder cancer incidence and mortality: A global overview and recent trends. Eur Urol. 2017;71:96\u2013108.","journal-title":"Eur Urol"},{"key":"1760_CR3","doi-asserted-by":"publisher","first-page":"e310","DOI":"10.1002\/ctm2.310","volume":"11","author":"L Tao","year":"2021","unstructured":"Tao L, Mu X, Chen H, et al. FTO modifies the m6A level of MALAT and promotes bladder cancer progression. Clin Transl Med. 2021;11:e310.","journal-title":"Clin Transl Med"},{"key":"1760_CR4","first-page":"293","volume":"43","author":"HZ Li","year":"2021","unstructured":"Li HZ, Zheng RS, Du LB, et al. [Bladder cancer incidence, mortality and Temporal trends in China]. Zhonghua Zhong Liu Za Zhi. 2021;43:293\u20138.","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"1760_CR5","first-page":"127","volume":"59","author":"SM Troyanovsky","year":"1992","unstructured":"Troyanovsky SM, Leube RE, Franke WW. Characterization of the human gene encoding cytokeratin 17 and its expression pattern. Eur J Cell Biol. 1992;59:127\u201337.","journal-title":"Eur J Cell Biol"},{"key":"1760_CR6","doi-asserted-by":"publisher","first-page":"346","DOI":"10.7150\/jca.19838","volume":"9","author":"H Hu","year":"2018","unstructured":"Hu H, Xu DH, Huang XX, et al. Keratin17 promotes tumor growth and is associated with poor prognosis in gastric cancer. J Cancer. 2018;9:346\u201357.","journal-title":"J Cancer"},{"key":"1760_CR7","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.2147\/CMAR.S243129","volume":"12","author":"D Li","year":"2020","unstructured":"Li D, Ni XF, Tang H, et al. KRT17 functions as a tumor promoter and regulates proliferation, migration and invasion in pancreatic cancer via mTOR\/S6k1 pathway. Cancer Manag Res. 2020;12:2087\u201395.","journal-title":"Cancer Manag Res"},{"key":"1760_CR8","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1007\/s00432-012-1202-6","volume":"138","author":"R Kitamura","year":"2012","unstructured":"Kitamura R, Toyoshima T, Tanaka H, et al. Association of cytokeratin 17 expression with differentiation in oral squamous cell carcinoma. J Cancer Res Clin Oncol. 2012;138:1299\u2013310.","journal-title":"J Cancer Res Clin Oncol"},{"key":"1760_CR9","doi-asserted-by":"publisher","first-page":"818416","DOI":"10.3389\/fcell.2022.818416","volume":"10","author":"H Zhang","year":"2022","unstructured":"Zhang H, Zhang Y, Xia T, et al. The role of Keratin17 in human tumours. Front Cell Dev Biol. 2022;10:818416.","journal-title":"Front Cell Dev Biol"},{"key":"1760_CR10","doi-asserted-by":"publisher","first-page":"5203","DOI":"10.1200\/JCO.2007.12.3141","volume":"25","author":"TM Tuttle","year":"2007","unstructured":"Tuttle TM, Habermann EB, Grund EH, et al. Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment. J Clin Oncol. 2007;25:5203\u20139.","journal-title":"J Clin Oncol"},{"key":"1760_CR11","doi-asserted-by":"publisher","first-page":"572494","DOI":"10.3389\/fmed.2020.572494","volume":"7","author":"Y Zeng","year":"2020","unstructured":"Zeng Y, Zou M, Liu Y, et al. Keratin 17 suppresses cell proliferation and Epithelial-Mesenchymal transition in pancreatic cancer. Front Med (Lausanne). 2020;7:572494.","journal-title":"Front Med (Lausanne)"},{"key":"1760_CR12","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/s41419-022-05261-2","volume":"13","author":"X Tan","year":"2022","unstructured":"Tan X, Liu Z, Wang Y, et al. miR-138-5p-mediated HOXD11 promotes cell invasion and metastasis by activating the FN1\/MMP2\/MMP9 pathway and predicts poor prognosis in penile squamous cell carcinoma. Cell Death Dis. 2022;13:816.","journal-title":"Cell Death Dis"},{"key":"1760_CR13","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41580-020-0237-9","volume":"21","author":"J Yang","year":"2020","unstructured":"Yang J, Antin P, Berx G, et al. Guidelines and definitions for research on epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 2020;21:341\u201352.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1760_CR14","doi-asserted-by":"publisher","first-page":"103557","DOI":"10.1016\/j.jprot.2019.103557","volume":"211","author":"Z Liu","year":"2020","unstructured":"Liu Z, Yu S, Ye S, et al. Keratin 17 activates AKT signalling and induces epithelial-mesenchymal transition in oesophageal squamous cell carcinoma. J Proteom. 2020;211:103557.","journal-title":"J Proteom"},{"key":"1760_CR15","doi-asserted-by":"publisher","first-page":"3000","DOI":"10.1111\/febs.14162","volume":"284","author":"L Wu","year":"2017","unstructured":"Wu L, Han L, Zhou C, et al. TGF-beta1-induced CK17 enhances cancer stem cell-like properties rather than EMT in promoting cervical cancer metastasis via the ERK1\/2-MZF1 signaling pathway. FEBS J. 2017;284:3000\u201317.","journal-title":"FEBS J"},{"key":"1760_CR16","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1158\/1541-7786.MCR-21-0866","volume":"20","author":"O McGinn","year":"2022","unstructured":"McGinn O, Riley D, Finlay-Schultz J, et al. Cytokeratins 5 and 17 maintain an aggressive epithelial state in Basal-Like breast cancer. Mol Cancer Res. 2022;20:1443\u201355.","journal-title":"Mol Cancer Res"},{"key":"1760_CR17","first-page":"45","volume":"19","author":"M Sarier","year":"2021","unstructured":"Sarier M, Usta SS, Turgut H, et al. Prognostic value of HPV DNA in urothelial carcinoma of the bladder: A preliminary report of 2-Year Follow-up results. Urol J. 2021;19:45\u20139.","journal-title":"Urol J"},{"key":"1760_CR18","doi-asserted-by":"publisher","first-page":"40","DOI":"10.5603\/FHC.a2021.0005","volume":"59","author":"C Li","year":"2021","unstructured":"Li C, Su H, Ruan C, et al. Keratin 17 knockdown suppressed malignancy and cisplatin tolerance of bladder cancer cells, as well as the activation of AKT and ERK pathway. Folia Histochem Cytobiol. 2021;59:40\u20138.","journal-title":"Folia Histochem Cytobiol"},{"key":"1760_CR19","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1093\/ajcp\/aqab050","volume":"156","author":"S Babu","year":"2021","unstructured":"Babu S, Kim NW, Wu M, et al. Keratin 17 is a novel cytologic biomarker for urothelial carcinoma diagnosis. Am J Clin Pathol. 2021;156:926\u201333.","journal-title":"Am J Clin Pathol"},{"key":"1760_CR20","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1080\/10799893.2020.1830110","volume":"41","author":"L Liu","year":"2021","unstructured":"Liu L, Sun L, Zheng J, et al. Berberine modulates keratin 17 to inhibit cervical cancer cell viability and metastasis. J Recept Signal Transduct Res. 2021;41:521\u201331.","journal-title":"J Recept Signal Transduct Res"},{"key":"1760_CR21","doi-asserted-by":"crossref","unstructured":"Nair RR, Hsu J, Jacob JT et al. A role for keratin 17 during DNA damage response and tumor initiation. Proc Natl Acad Sci U S A 2021;118.","DOI":"10.1073\/pnas.2020150118"},{"key":"1760_CR22","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.humpath.2019.09.005","volume":"94","author":"JDK Bai","year":"2019","unstructured":"Bai JDK, Babu S, Roa-Pena L, et al. Keratin 17 is a negative prognostic biomarker in high-grade endometrial carcinomas. Hum Pathol. 2019;94:40\u201350.","journal-title":"Hum Pathol"},{"key":"1760_CR23","doi-asserted-by":"publisher","first-page":"151975","DOI":"10.1016\/j.acthis.2022.151975","volume":"125","author":"A Mlicka","year":"2023","unstructured":"Mlicka A, Mlicki P, Niewiadomski P, et al. Synergistic effect of Metformin and doxorubicin on the metastatic potential of T24 cells. Acta Histochem. 2023;125:151975.","journal-title":"Acta Histochem"},{"key":"1760_CR24","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s13046-021-01935-5","volume":"40","author":"Q Wu","year":"2021","unstructured":"Wu Q, Zhou X, Li P, et al. ROC1 promotes the malignant progression of bladder cancer by regulating p-IkappaBalpha\/NF-kappaB signaling. J Exp Clin Cancer Res. 2021;40:158.","journal-title":"J Exp Clin Cancer Res"},{"key":"1760_CR25","doi-asserted-by":"publisher","first-page":"4824902","DOI":"10.1155\/2019\/4824902","volume":"2019","author":"DW Tian","year":"2019","unstructured":"Tian DW, Wu ZL, Jiang LM, et al. KIF5A promotes bladder cancer proliferation in vitro and in vivo. Dis Markers. 2019;2019:4824902.","journal-title":"Dis Markers"},{"key":"1760_CR26","doi-asserted-by":"publisher","first-page":"4782","DOI":"10.12659\/MSM.909350","volume":"24","author":"J Liu","year":"2018","unstructured":"Liu J, Liu L, Cao L, et al. Keratin 17 promotes lung adenocarcinoma progression by enhancing cell proliferation and invasion. Med Sci Monit. 2018;24:4782\u201390.","journal-title":"Med Sci Monit"},{"key":"1760_CR27","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s13046-019-1043-0","volume":"38","author":"R Wei","year":"2019","unstructured":"Wei R, Xiao Y, Song Y, et al. FAT4 regulates the EMT and autophagy in colorectal cancer cells in part via the PI3K-AKT signaling axis. J Exp Clin Cancer Res. 2019;38:112.","journal-title":"J Exp Clin Cancer Res"},{"key":"1760_CR28","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3389\/fneur.2020.00297","volume":"11","author":"D Wu","year":"2020","unstructured":"Wu D, Wang C. miR-155 regulates the proliferation of glioma cells through PI3K\/AKT signaling. Front Neurol. 2020;11:297.","journal-title":"Front Neurol"},{"key":"1760_CR29","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.2147\/OTT.S196150","volume":"12","author":"Y Yang","year":"2019","unstructured":"Yang Y, Yin S, Li S, et al. Stanniocalcin 1 in tumor microenvironment promotes metastasis of ovarian cancer. Onco Targets Ther. 2019;12:2789\u201398.","journal-title":"Onco Targets Ther"},{"key":"1760_CR30","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1002\/med.21948","volume":"43","author":"HL Ang","year":"2023","unstructured":"Ang HL, Mohan CD, Shanmugam MK, et al. Mechanism of epithelial-mesenchymal transition in cancer and its regulation by natural compounds. Med Res Rev. 2023;43:1141\u2013200.","journal-title":"Med Res Rev"},{"key":"1760_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.semcancer.2024.03.002","volume":"100","author":"AQ Khan","year":"2024","unstructured":"Khan AQ, Hasan A, Mir SS, et al. Exploiting transcription factors to target EMT and cancer stem cells for tumor modulation and therapy. Semin Cancer Biol. 2024;100:1\u201316.","journal-title":"Semin Cancer Biol"},{"key":"1760_CR32","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.1016\/j.xphs.2017.03.011","volume":"106","author":"T Tomono","year":"2017","unstructured":"Tomono T, Yano K, Ogihara T. Snail-Induced Epithelial-to-Mesenchymal transition enhances P-gp-Mediated multidrug resistance in HCC827 cells. J Pharm Sci. 2017;106:2642\u20139.","journal-title":"J Pharm Sci"}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-025-01760-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12894-025-01760-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-025-01760-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T02:18:51Z","timestamp":1743992331000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcurol.biomedcentral.com\/articles\/10.1186\/s12894-025-01760-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,7]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1760"],"URL":"https:\/\/doi.org\/10.1186\/s12894-025-01760-4","relation":{},"ISSN":["1471-2490"],"issn-type":[{"value":"1471-2490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,7]]},"assertion":[{"value":"27 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the Affiliated Hospital of Hebei University(Ethics Approval Number: 2019\u2009\u2212\u20090115).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki. Written informed consent has been obtained from the patient(s) to publish this paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent statement"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"77"}}